TONMYA 2.8 MG TABLET SL
FDA nonproprietary name: cyclobenzaprine hydrochloride
For 30 tablets
Pharmacies pay
$888.29 filed
30 × $29.60952 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$1,026.53 estimated
$888.29 + $133.24 (15%) + $5.00 fee per fill = $1,026.53
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
TONMYA 2.8 MG TABLET SL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cyclobenzaprine hydrochloride, under the trade name “TONMYA”.
FDA gives its dosage form as tablet, orally disintegrating and its route as sublingual.
The labeler, the company named on the label, is Tonix Medicines, Inc.
FDA’s Established Pharmacologic Class for it is Muscle Relaxant.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $888.29 for 30 tablets (30 × $29.60952 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · NADAC explanation codes
All 2 NDCs
- 70792-0102-30 · Tonix Medicines, Inc. · $29.60952 per EA · eff. 2026-09-23 filed
- 70792-0102-60 · Tonix Medicines, Inc. · $29.60952 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
8 other products in the NADAC file share the FDA nonproprietary name cyclobenzaprine hydrochloride with TONMYA 2.8 MG TABLET SL.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| AMRIX ER 15 MG CAPSULE | $66.23256 per EA filed | We don’t know yet |
| AMRIX ER 30 MG CAPSULE | $66.56709 per EA filed | We don’t know yet |
| CYCLOBENZAPRINE 5 MG TABLET | $0.02197 per EA filed | $0.14207 per EA filed |
| CYCLOBENZAPRINE 7.5 MG TABLET | $0.26288 per EA filed | $0.14207 per EA filed |
| CYCLOBENZAPRINE 10 MG TABLET | $0.01712 per EA filed | $0.14207 per EA filed |
| CYCLOBENZAPRINE ER 15 MG CAP | $1.18556 per EA filed | We don’t know yet |
| CYCLOBENZAPRINE ER 30 MG CAP | $1.0822 per EA filed | We don’t know yet |
| FEXMID 7.5 MG TABLET | $0.26288 per EA filed | $0.14207 per EA filed |
| TONMYA 2.8 MG TABLET SL this page | $29.60952 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $29.60952 per EA filed.
Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 2 have a higher middle NADAC price and 20 a lower one. The one in the middle is CARISOPRODOL 250 MG TABLET, at $0.47389 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 30 tablets?
- NADAC prices this product per EA, and the FDA NDC Directory lists all 2 of its NDCs as a tablet taken under the tongue (dosage form “TABLET, ORALLY DISINTEGRATING”, route “SUBLINGUAL”), so one EA is one tablet. OpenBill counts a tablet or film taken under the tongue or against the cheek as an oral solid, like one that is swallowed. The card starts at 30 tablets, a common one-month supply of a once-a-day medicine; change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- METHOCARBAMOL 1,000 MG TABLET
- CARISOPRODOL 250 MG TABLET
- METAXALONE 400 MG TABLET
- ORPHENADRINE ER 100 MG TABLET
- CHLORZOXAZONE 250 MG TABLET